USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
SÜDPACK is setting standards in terms of both performance and sustainability
To enable company to be future-ready by tapping potential in CDMO space
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Subscribe To Our Newsletter & Stay Updated